Larry BauerSr. Regulatory Drug Expert at Hyman, Phelps, & McNamara, P.C.
Larry Bauer is a Sr. Regulatory Drug Expert with Hyman, Phelps, & McNamara, P.C. and assists medical product industry and patient advocacy organization clients in a wide range of regulatory matters, including new drug and biologic development and approval issues. Prior to this position he worked at the FDA in CDER’s Rare Diseases Program working on policy, education, and science related to rare disease drug development. He has expertise in Rare Pediatric Disease priority review vouchers and designations, expedited programs, and patient engagement including extensive experience guiding patient advocacy groups. He also serves on the National Organization for Rare Disorders (NORD) Advocacy Committee.